Civik Thomas 4
4 · FIVE PRIME THERAPEUTICS, INC. · Filed Apr 14, 2020
Insider Transaction Report
Form 4
Civik Thomas
DirectorPresident and CEO
Transactions
- Award
Common Stock
2020-04-13+75,000→ 75,000 total - Award
Employee Stock Option (right to buy)
2020-04-13+480,000→ 480,000 totalExercise: $2.72Exp: 2030-04-12→ Common Stock (480,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of April 13, 2021, 2022 and 2023, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]This option will vest with respect to one-fourth (1/4) of the shares subject to this option on April 13, 2021 and with respect to one forty-eighth (1/48) of the shares subject to this option monthly thereafter, provided the reporting person provides services to the Company through each such date.